keep away from direct sunlight,store under nitrogen
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Taniborbactam dihydrochloride (VNRX-5133 dihydrochloride) is a selective and potent novel cyclic boronic acid β-lactamase inhibitor with antimicrobial activity and significant inhibition of Gram-negative bacteria.Taniborbactam dihydrochloride inhibits KPC Taniborbactam dihydrochloride inhibits KPC-2, AmpC, OXA-48 and VIM-2 and can be used for the study of fungal infections.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 263.00 | |
5 mg | In stock | $ 645.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | 10-14 weeks | $ 1,860.00 | |
50 mg | 10-14 weeks | $ 2,880.00 |
Description | Taniborbactam dihydrochloride (VNRX-5133 dihydrochloride) is a selective and potent novel cyclic boronic acid β-lactamase inhibitor with antimicrobial activity and significant inhibition of Gram-negative bacteria.Taniborbactam dihydrochloride inhibits KPC Taniborbactam dihydrochloride inhibits KPC-2, AmpC, OXA-48 and VIM-2 and can be used for the study of fungal infections. |
Targets&IC50 | KPC2:0.5 nM, VIM-2:0.06 nM, VIM-4:0.5 nM, OXA-48:2 nM |
In vitro | Taniborbactam dihydrochloride (VNRX-5133 dihydrochloride) exhibits IC50 values of 0.5 nM, 2 nM, 0.5 nM, and 0.06 nM against KPC-2, OXA-48, VIM-4 strains of Klebsiella pneumoniae, and VIM-2 strain of Pseudomonas aeruginosa, respectively[1].The combination of Cefepime/Taniborbactam dihydrochloride (10 μg/mL) and Meropenem/Taniborbactam dihydrochloride shows MIC ranges of 16-0.25 μg/mL and 1-0.125 μg/mL against strains derived from Klebsiella pneumoniae and Escherichia coli, respectively[2]. |
In vivo | In a single-dose mouse lung infection model with neutropenia, a single dose of Cefepime at 32 mg/kg combined with Taniborbactam dihydrochloride (VNRX-5133 dihydrochloride) at 16 mg/kg (subcutaneous injection) results in a reduction of bacterial counts by >4 log10. This combination is effective against K. pneumoniae strains producing CTX-M-14[1].In a combination treatment in a kidney infection model, Cefepime at 16 mg/kg and Taniborbactam dihydrochloride at 16 mg/kg (subcutaneous injection, twice daily for 7 days) lead to a reduction of bacterial counts by >2 log10 in the kidneys, targeting E. coli strains producing CTX-M-15[2].The half-life (T1/2) of Taniborbactam dihydrochloride in mice is 0.16 hours, with a clearance (CL) of 618 mL/h/kg and a volume of distribution at steady state (Vss) of 143 mL/kg[1]. |
Synonyms | VNRX-5133 dihydrochloride, Taniborbactam 2HCl |
Molecular Weight | 462.18 |
Formula | C19H30BCl2N3O5 |
CAS No. | 2244235-49-0 |
keep away from direct sunlight,store under nitrogen
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 30 mg/mL (64.91 mM), Sonication is recommended.
DMSO: 100 mg/mL (216.37 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Taniborbactam dihydrochloride 2244235-49-0 Microbiology/Virology Antibacterial Antifungal VNRX 5133 Hydrochloride VNRX5133 Hydrochloride VNRX-5133 dihydrochloride Taniborbactam 2HCl VNRX-5133 Hydrochloride Taniborbactam Hydrochloride inhibitor inhibit